---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-047151"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2024-05-28T23:59:59+00:00"
generated_at: "2026-06-01T08:27:59.528529+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Emmaus Life Sciences amends bylaws to establish exclusive forum for stockholder litigation

## Summary
- Board adopted Amendment to Amended and Restated By-Laws on May 23, 2024.
- Delaware Chancery Court designated as sole forum for derivative and internal affairs actions.
- Federal district courts designated as exclusive forum for Securities Act claims.
- Amendment effective immediately; shareholders deemed to have consented.
- Exclusive forum provisions apply to actions based on duties, DGCL, and internal affairs.

## SEC filing metadata
- accession: 0001213900-24-047151
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2024-05-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390024047151/0001213900-24-047151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390024047151/ea0206971-8k_emmaus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-047151
- JSON: https://secwatch.observer/filing/0001213900-24-047151.json
- Plain text: https://secwatch.observer/filing/0001213900-24-047151.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.